REVIEW Azelastine competes with histamine for the H1-receptor sites on effector cells and acts as an antagonist by inhibiting the release of histamine and other mediators involved in the allergic response.
REFERENCES
[1]
Lumry W, Prenner B, Corren J, Wheeler W (September 2007). Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily. Annals of Allergy, Asthma & Immunology 99 (3): 267-72. doi:10.1016/S1081-1206(10)60663-1. PMID 17910331.
[2]
Ciprandi G, Ricca V, Passalacqua G, et al. (March 1997). Seasonal rhinitis and azelastine: long- or short-term treatment?. The Journal of Allergy and Clinical Immunology 99 (3): 301-7. doi:10.1016/S0091-6749(97)70046-0. PMID 9058684.
[3]
Horak, Friedrich; Zieglmayer, Ursula Petra (2009). Azelastine nasal spray for the treatment of allergic and nonallergic rhinitis. Expert Review of Clinical Immunology 5 (6): 659-69. doi:10.1586/eci.09.38. PMID 20477689.
[4]
Greiff L, Andersson M, Svensson C, Persson CG (April 1997). Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways. Clinical and Experimental Allergy 27 (4): 438-44. doi:10.1111/j.1365-2222.1997.tb00730.x. PMID 9146938.
All products are stocked and shipped from San Francisco Bay Area, California, USA.
⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.
Add to Favorites 
Delete from Favorites 
